Trial Profile
Non-Interventional Study (NIS) in Patients With Restless Legs Syndrome (RLS) to Assess the Effectiveness and Safety of Neupro in Daily Practise.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Jul 2011
Price :
$35
*
At a glance
- Drugs Rotigotine (Primary)
- Indications Restless legs syndrome
- Focus Therapeutic Use
- Sponsors UCB
- 22 Jul 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 14 Jul 2011 Planned end date changed from Jun 2011 to Jul 2011 as reported by ClinicalTrials.gov.
- 25 May 2011 Planned end date changed from 1 May 2011 to 1 Jun 2011 as reported by ClinicalTrials.gov.